Evidence map›Paper›PMID 31654383›Full record

ArticleNeurotoxicity research2020

Autophagy and Ubiquitin-Proteasome System Coordinate to Regulate the Protein Quality Control of Neurodegenerative Disease-Associated DCTN1.

Nana Wang, Qilian Ma, Panpan Peng, Yunhao Yu, Shiqiang Xu, Guanghui Wang, Zheng Ying, Hongfeng Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Dysregulated Dynein-Mediated Trafficking of Nephrin Causes INF2-related Podocytopathy.Journal of the American Society of Nephrology : JASN · 2021
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nana WangJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Qilian MaJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Panpan PengJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Yunhao YuJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Shiqiang XuJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Guanghui WangJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China.
Zheng YingJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China. zheng.ying@suda.edu.cn.ORCID http://orcid.org/0000-0002-1099-0509
Hongfeng WangJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, |Soochow University, Suzhou, 215123, Jiangsu, China. wanghongfeng@suda.edu.cn.
Soochow University · CNChina Pharmaceutical University · CNYantai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motor neuron diseases are neurodegenerative diseases that are characterized by degeneration of the upper and lower motor neurons in the central nervous system. Mutations in Dynactin 1 (DCTN1), a component in the Dynein/Dynactin motor complex, have been previously identified to cause motor neuron diseases and other neurodegenerative disorders. Recent studies showed that motor neuron disease-linked mutation, such as G59S mutation, could lead to dysfunction and protein aggregation of DCTN1. However, the cellular pathway involved in the clearance of DCTN1 aggregates is still not fully elucidated. In this study, we employed a culture cell model of DCTN1-linked neurodegeneration and explored the role of cellular protein control systems in the regulation of wild type and mutant DCTN1. We find that the ubiquitin-proteasome system, but not autophagy, is the primary protein degradation system for the turnover of both wild type and G59S DCTN1 under normal conditions. However, it turns out that autophagy can play a role in the clearance of protein aggregates of G59S DCTN1 when the proteasome activity is inhibited. Importantly, overexpression of TFEB, a master regulator of autophagy, promotes the autophagic clearance of G59S DCTN1 aggregates and ameliorates G59S DCTN1-induced cytotoxicity when the proteasomes are impaired. In conclusion, autophagy may play as a backup system to protect cells against the cytotoxicity induced by aggregate-prone DCTN1 when proteasomal function is damaged.

Indexed as

ProteolysisAnimalsAutophagyCells, CulturedCell SurvivalDynactin ComplexHumansMiceMicrotubulesMutationNeurodegenerative DiseasesPlasmidsProteasome Endopeptidase ComplexProtein Aggregation, PathologicalTransfectionUbiquitinDCTN1 protein, humanDynactin ComplexProteasome Endopeptidase ComplexUbiquitinAutophagyNeurodegenerative diseaseProteasomeProtein aggregationTFEB

Identifiers

PMID31654383
OpenAlexW2981978976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.